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ABSTRACT
Human cell free extracts carry out nucleotide excision
repair in vitro. The extract is readily separated into two
fractions by chromatography on a DEAE column.
Neither the low salt (0.1 M KCI) nor the high salt (0.8
M KCI) fractions are capable of repair synthesis but the
combination of the two restore the repair synthesis
activity. Using the repair synthesis assay we purified
a protein of 37 kDa from the high salt fraction which
upon addition to the low salt fraction restores repair
synthesis activity. Amino acid sequence analysis,
amino acid composition and immunobloting with PCNA
antibodies revealed that the 37 kDa protein is the
proliferating cell nuclear antigen (PCNA) known to
stimulate DNA Polymerases 6 and e. By using an assay
which specifically measures the excision of thymine
dimers we found that PCNA is not required for the
actual excision reaction perse but increases the extent
of excision by enabling the excision repair enzyme to
turn over catalytically.
INTRODUCTION
The human syndrome xeroderma pigmentosum (XP) is
characterized phenotypically by UV sensitivity, genotypically by
mutations in seven genes (XPA-G), and biochemically by
defective removal of pyrimidine dimers and DNA adducts caused
by UV-mimetic agents (1). It has been generally assumed that
XP genes encode the subunits of a human nuclease system which
excises the modified nucleotides. The cloning of genes which
complement the defects of XP-A (2), XP-B (3), and of XP-D
(4) have revealed DNA sequences that encode for proteins with
zinc finger, ATPase, and helicase motifs. These observations have
led credence to this notion. Furthermore, Robins et al. (5) have
recently used an in vitro repair synthesis complementation assay
to purify the XP-A protein and have shown that the protein binds
preferentially to UV-damaged DNA. However, some reports
indicate that XP mutants are capable of removing thymine dimers
from DNA in vitro (6,7) raising the possibility that purification
of XP complementing proteins might not be sufficient to
reconstitute the human excision nuclease system. Therefore, we
decided to use a 'resolution and reconstitution' assay (8) with
cell-free extract, rather than in vitro complementation, to purify
the components of the human nucleotide excision nucleases from
a cell free extract.
We used the repair synthesis assay (9-13) to monitor the
purification of proteins involved in nucleotide excision repair and
to identify a homogeneous protein of 37 kDa. Protein chemistry
analyses revealed that this protein is the well-characterized
proliferating cell nuclear antigen (PCNA).
MATERIALS AND METHODS
Materials
HeLa S3 cells were from the stock of Lineberger Cancer
Research Center (University of North Carolina). Cells were
grown in suspension to a titer of 5-8 x i05 cells/ml. DEAE
Bio-Gel A and hydroxyapatite (Bio-Gel-HT) were purchased from
Bio-Rad, phenyl sepharose from Sigma, and Ultrogel AcA34
from IBF Biotechnics, Inc. The following buffers were used in
resolution and reconstitution of repair synthesis activity: Buffer
A: 25mM HEPES, pH 7.9, 0.4 mM EDTA, 8 mM MgCl2,
1 mM dithiothreitol, and 17% glycerol. Buffer B: 25 mM
HEPES, pH 7.9, 100 mM KCI, 0.4 mM EDTA, 8 mM MgCl2,
and 1 mM dithiothreitol.
Purification of PCNA as a Repair Protein
All purification steps were carried out at 0-4°C. Activity and
purity of the fractions were monitored by reconstitution of repair
synthesis in vitro and by analysis on SDS-PAGE followed by
silver staining.
HeLa cell-free extract (CFE) was prepared by the method of
Manley et al. (14) and following the dialysis step CFE containing
180 mg protein was loaded onto a 30 ml DEAE Agarose column
preequilibrated with Buffer A + 100 mM KCI. Unbound proteins
(Fraction DI) were washed from the column with 60 ml of the
same buffer, and bound proteins (Fraction D2) were eluted with
60 ml of Buffer A + 800 mM KCI. Three-ml fractions were
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collected and the proteins were located by analyzing 2 Al of each
fraction by SDS-PAGE. The peak fractions of low salt and high
salt eluates were combined separately. The low salt eluate (DI)
was divided into 100 l, aliquots and stored at -80°C. The high
salt eluate (D2, 9 ml) was processed further.
Fraction D2 (8 ml) was adjusted to 20% saturated ammonium
sulfate and applied to a 12-ml phenyl sepharose column
preequilibrated with 20% saturated ammonium sulfate in Buffer
B. The column was washed with 12 ml of the same buffer and
developed with a step gradient (5 steps of 6 ml) of20% saturated
ammonium sulfate to 40% ethylene glycol and a final elution with
24 ml 50% ethylene glycol, all in Buffer B. Three-ml fractions
were collected. The active fraction (PS), which eluted with 50%
ethylene glycol, was dialyzed against Buffer A + 100 mM KCI
and concentrated to 1 ml by ultrafiltration in Centricon 10
(Fraction PS).
Fraction PS was loaded on a 125 ml (1.6 cmx60 cm) AcA34
column which had been calibrated with Sigma SDS-7 molecular
weight markers as described by Laue and Roberts (1990) and
equilibrated with Buffer A + 100 mM KCl. The column was
developed with the same buffer, collecting 2 ml fractions. The
activity eluted at fractions corresponding to 80 kDa molecular
weight. The active fractions were combined (12 ml) and dialyzed
against 20 mM potassium phosphate pH 6.8, 0.4 mM EDTA,
1 mM dithiothreitol, and 17% glycerol (Fraction SC).
Fraction SC (7 ml) was applied to a 5 ml hydroxyapatite
column and the column was developed with a 50 ml gradient
of 20 mM to 200 mM potassium phosphate, pH 6.8, collecting
2 ml fractions. The active fraction eluted at 75 mM potassium
phosphate (Fraction HAl). Chromatography on hydroxyapatite
was repeated with a smaller column (2 ml) and a smaller gradient
(10 ml) to obtain an active fraction (1.5 ml) with a single protein
as determined by silver staining of SDS-PAGE (Fraction HA2).
Assays
The repair synthesis assay which measures the incorporation of
radiolabeled nucleoside into damaged DNA by CFE or a mixture
of column fractions was conducted as described by Wood et al.
(9) and Sibghat-Ullah et al. (1 1) except 4 j1Ci[a32P] dCTP, 61
mM KCl and 6.8% glycerol per reaction were used. 30 itg of
the low salt eluate from DEAE-agarose (Dl fraction) was
incapable of repair synthesis, but activity could be reconstituted
by addition of 30 itg of the high salt eluate (Fraction D2). D2
was subjected to further purification on additional resins, and
monitored by restoration of repair synthesis activity to Dl.
The excision repair assay measures the release of oligomers
containing thymine dimers and was conducted as described by
Huang et al. (15). Briefly, a semisynthetic plasmid containing
four cyclobutane thymine dimers (T< >T) at predetermined sites
and 32P label at the 11th phosphodiester bond 5' to the T< >Ts
was incubated with CFE or mixtures of column fractions in 50
Dl + + - - + +
D2 - - + + + +
PCNA - - - - -




The amino acid composition of the purified protein and the amino
acid sequence of a product from typtic digestion were determined
at the Yale Protein Chemistry Facility by Kathy Stone and Dr.
Ken Williams. The sequence obtained from the tryptic peptide
was compared with the sequences at the Protein Sequence
Database, Protein Identification Resource, National Biomedical
Research Foundation.
Substrates
Two substrates were used: pBR322 damaged with cisplatin (11)
for repair synthesis, and pUNC1991-4 containing 4 T< >Ts at
unique locations (15) for the excision assay. pBR322 and the
control plasmid pUC18 were purified through two cesium
chloride-ethidium bromide gradients and contained less than 2%
nicked DNA. To prepare Pt-adducted DNA, pBR322 was
incubated in 1 ml 10 mM Tris HCI, pH 8.0 and 1 mM EDTA
containing 59 nM DNA (plasmid) and 1.3 1sM cisplatin at room
temperature for 24 hrs. Unincorporated drug was removed by
dialysis against 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, and
1 mM EDTA. Cisplatin modification was performed in the dark
or under yellow light to prevent nicking and as a result the
modified DNA contained no more nicks than the control DNA.
The excision assay substrate pUNC1991-4 containing 32p
label at the 11th phosphodiester bonds 5' to the 4 T< >Ts located
at unique positions was prepared as described previously (19)




LANE 1 2 3 4 5 6 7 8 9
Fgure 1. Purfication of PCNA by Repair Synesis Resolution and Reconsfittion
Assay. On the left are the autoradiographs of repair synthesis assays conducted
with control (-) DNA or cisplatin adducted (Pt)DNA. On the right is a schematic
of the separation procedure employed to obtain a pure protein essential for repair
synthesis activity. Each repair synthesis reaction contained 30 jg Dl and/or 10
Al of the active fraction from the indicated column.
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Id repair synthesis buffer (11) with or without dNTPs as indicated.
Incubation was at 30°C for 2 hrs. Afterwards the DNA was
deproteinized by proteinase K and phenol extraction, precipitated
with ethanol, redissolved in formamide-dye and analyzed on 10%
polyacrylamide DNA sequencing gel. The excision products are
seen as bands of27-29 nucleotides on an autoradiograph of the
gel.
Other Methods
Protein concentration of cell-free extract and DEAE and phenyl
Sepharose fractions was determined by Bradford assay (16) using
Bio-Rad reagents and bovine serum albumin as standard. Protein
concentration of AcA34 and hydroxyapatite fractions was
determined by Silver staining and amino acid analysis by the
ninhydrin method. SDS-PAGE was done by the method of
Laemmli (17) and the gels were silver stained as described by
Morrissey et al. (18), using Bio-Rad developer. Autoradiographs,
photographs of ethidium bromide stained gels, and silver stained
SDS-polyacrylamide gels were scanned with a Zeineh Softlaser
Scanning Densitometer (Fullerton, CA) for quantifying radiolabel
incorporation, DNA, and protein, respectively.
Table 1. Purification of PCNA as a Repair Protein
Total Specific
Fraction Volume (ml) Protein (mg)a Activity
1. Cell-free Extract 18.5 ml 178.7 8
2. DEAE (D2) 9 20.7 18
3. Phenylsepharose (PS) 3 0.44 307
4. AcA34 (SC) 12 0.19 3106
5. Hydroxyapatite I(HA1) 2 0.02 8400
6. Hydroxyapatite II(HA2) 1.5 0.01 11200
aThese numbers are based on the assumption that the entirety of each fraction















Resolution and Reconstitution of Repair Synthesis Activity
To isolate the subunits of the human excision nuclease(s) we
decided to separate HeLa CFE into two fractions unable to carry
out repair synthesis and then purify the protein(s) necessary for
activity from each of these fractions. Fig. 1 shows that passing
the CFE extract through a DEAE resin equilibrated with 0.1 M
KCI is sufficient for the initial separation. About 80% of the
proteins pass through the column (DI) while the 20% which are
retained are eluted with 0.8 M KCI (D2). Although the low-salt
fraction contains some residual repair synthesis activity, the high
salt fraction is completely devoid of activity. Yet upon addition
of D2 to the low-salt fraction the repair synthesis signal is
enhanced by a factor of 5-10. Therefore we decided that D2
contained one or more proteins necessary for carrying out
nucleotide excision repair synthesis and proceeded to purify these
proteins. The DEAE high salt fraction was further purified
through successive chromatography on phenyl sepharose, AcA34
(gel permeation), and hydroxyapatite resins. The activity always
eluted as a single peak as evidenced by the fact that mixing with





























Figure 2. Hydroxyapatite Column Activity Profile. Fractions of 0.5 ml were
collected and tested for repair synthesis complementing activity upon addition
to the DI fraction. The top panel shows an autoradiogram of the repair synthesis
assays and in the bottom panel the elution profile of the 37 kDa protein is compared
to the activity profile. Substrate(S) DNA is 300 ng pBR322, 25 cisplatin
adducts/plasmid. and control (C) is 300 ng pUC18, unmodified. Protein
concentrations were determined by silver staining of SDS-polyacrylamide gels
and amino acid analysis by the ninhydrin method.
4 5 6 7 8
FRACTION NUMBER
9
Figure 3. SDS-PAGE Analysis of the Purification Fractions. The following
amounts of protein were loaded into the lanes; cell free extract (CFE) 10 jig;
High Salt DEAE (DE), 4 itg; Phenyl Sepharose (PS), 2 isg; AcA34 (SC), 1 sg;
Hydroxylapatite I (HAl), 0.2 1tg; Hydroxylapatite II (HA2), 0.1 Fg. The gel
was silver stained. The mass of the size markers are indicated on the side.
D:2:]
2444 Nucleic Acids Research, Vol. 20, No. 10
synthesis signal achieved with Dl plus peak column fractions
(data not shown).
It thus appeared that the high-salt DEAE fraction contained
a single protein which was required to restore the repair synthesis
activity of D1. The activity eluted as a protein of 80 kDa
molecular weight on the sizing column and coincided with a
polypeptide of Mr= 37,000 at the final purification step on a
hydroxyapatite column (Fig. 2). Thus, we concluded that the
repair protein was a dimer of a 40 kDa polypeptide. Table 1
summarizes the purification steps and in Fig. 3 the fractions are
analyzed by SDS-PAGE and silver staining. Specific activity is
expressed as pmole of dCMP incorporated/mg protein. In a
standard repair synthesis reaction mixture, containing 50 ug HeLa
Table 2. Amino acid Compositions of the 'Repair Protein' and PCNA



















"Based on 232 amino acids not including cys, gly, arg and trp which were not
determined (ND).
bComposition based on published sequence (19).






Figure 4. Excision ofT< >T in the Absence ofPCNA. DNA containing intemal
label located at the I Ith phosphodiester bond 5' to T< >Ts was incubated with
Dl with or without D2 (75 nM PCNA) or purified PCNA (25 nM) in the absence
or presence of dNTPs as indicated. The reaction products were then analyzed
on a 10% sequencing gel. Equal amounts of radioactivity were loaded into all
lanes. The positions of the primary excision products are marked by arrows.
cell-free extract and 0.3 tg of Pt-adducted pBR322, 400 fmol
dCMP is incorporated in 2 hours at 30°C.
PCNA is a Repair Protein
It is apparent from Fig. 3 that after the final purification step
restoration of repair synthesis activity to DI is associated with
a single protein. To gain a better understanding of the role of
this protein in repair we obtained the amino acid composition
and compared it to other proteins of similar molecular weight
which are known to be involved in DNA repair, namely the XP-A
protein and DNA polymerase ,B. The amino acid composition
shown in Table 2 is entirely different from those of the latter
two proteins. To further characterize our protein we cleaved the
protein with trypsin and cyanogen bromide, isolated fragments
and sequenced one which was in reasonable yield and high purity.
The 17- amino acid sequence obtained -SQTSNVDKEEEAVTIE-
was in complete agreement with the residues 182-198 ofhuman
proliferating cell nuclear antigen, PCNA). Comparisons of the
two proteins (Table 2) determined that their compositions were
identical within experimental error. Dot immunoblotting with
PCNA monoclonal antibody positively identified the purified
protein as PCNA (data not shown). As further proof, human
PCNA was overexpressed in E. coi BL 21 (DE3) on pT7hPCNA
plasmid (K. Fien and B. Stillman, personal communication) as
described for S. cerevisiae PCNA (20). The overexpressed PCNA
was purified as described in Materials and Methods for HeLa
extract. Chromatographic behavior was identical for PCNA from
both sources, and the overexpressed protein substituted for
equivalent amounts of HeLa extract PCNA in the repair synthesis
assay (data not shown). Thus, we conclude that the repair protein
we have purified is PCNA.
Role of PCNA in Nucleotide Excision Repair
The identification of PCNA as a repair protein was not surprising
because in humans PCNA is known to stimulate DNA polymerase
6 (21) and polymerase e (22). Recent studies have implicated
polymerase e and 6 in repair synthesis following nucleotide
excision (23-25). We also considered the possibility that PCNA
might actually participate in nucleotide excision repair at a
preincision/excision step.
To find out whether PCNA participates in the excision or
resynthesis steps or both we conducted the excision assay with
various fractions and combinations in the absence or presence
of dNTPs. The excision assay which utilizes T< >T containing
Table 3. Effect of dNTP and PCNA on Excision and Repair Synthesis Activities.
Excision Activity' Repair Synthesis Activity
(fnole dCMP)
-dNTP + dNTPb - dNTPC + dNTPd
DI 100 264 -11 6 109
D2(PCNA) 0 0 0 0
D1+D2(PCNA) 245 20 463+55 5 748
a. Activity relative to D1-dNTP (100 arbiry units). Average of 3-4 experin
(k SEM).
b. 20 FM each of dATP, dCTP, dGTP and dlTP added to each 50 Id reaction.
c. 14 nM (4 pCi) [a32P]dCTP (specific activity 6000 Ci/immole) added to each
50 pI reaction.
d. 20 pM each of dATP, dGTP and dTTP, 8 pM dCTP and 4 Ci[(32P] dCTP
added to each 50 Id reaction.
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DNA with radiolabel in the vicinity of T < >T has been used
successfully by Huang et al. (15) to demonstrate that human cells
excise T < > T in 27-29 nucleotide-long oligomers by incising
at precise positions with regard to T< >T. Fig. 4 shows the
results of these experiments conducted with DI and with Dl plus
PCNA. As is apparent from the figure, DI (which has less than
3% of the amount of PCNA found in D2, as determined by dot
immunoblotting with monoclonal PCNA antibody, data not
shown) carries out excision in the absence of dNTPs (lane 1)
indicating that PCNA is not involved in the excision reaction per
se. In lane 2 it is seen that dNTPs stimulated the level of excision
even without PCNA. Addition of PCNA to Dl in the absence
of dNTPs also stimulated excision (lane 5 and 7). Maximum
stimulation was achieved in the presence of both dNTPs and
PCNA (lanes 6 and 8). These results (summarized in Table 3)
would imply that PCNA is involved in the resynthesis step by
stimulating the repair DNA polymerase.
EXCINUCLEASE + ft
+ ATP
5 nick 3 nick
=IIIIIIIIX















Figure 5. Proposed model for the role of PCNA in human nucleotide excision
repair synthesis. Step 1: Excision nuclease (Excinuclease, X) binds to DNA at
damage site and makes dual incisions 3' and 5' to the damage (19). Step 2: A
'primer recognition complex' forms (17) in the presence of PCNA (right side).
The excision nuclease is displaced stimulating enzymatic turnover. In the absence
of PCNA (left side), the post-incision complex remains intact. Step 3: Addition
of dNTPs results in gap filling by the repair polymerase, followed by ligation.
In the absence of PCNA (left side), the excinuclease is displaced by the repair
polymerase directly with concomitant gap filling. This mechanism is less efficient
overall with regard to enzymatic turnover than that involving PCNA in a 'primer
recognition complex' followed by gap filling. Abbreviations: Replication Factor
A, RF-A; Replication Factor C, RF-C; DNA Repair Polymerase, POL.
DISCUSSION
The results presented in this study raise two questions: which
DNA polymerase is involved in repair synthesis following
nucleotide excision repair and how does PCNA stimulate both
excision and repair synthesis.
Although all four nuclear DNA polymerases have been
implicated in nucleotide excision repair at one time or another,
the most recent evidence has implicated DNA polymerase c (26;
see 24). Syvaoja et al. (26) isolated DNA polymerases 6 and e
from HeLa cells and, using a permeabilized cell system, found
that addition of polymerase E but not polymerase 6 resulted in
UV-induced repair synthesis. Lee et al. (22) have reported that
PCNA can stimulate in vitro DNA synthesis by both DNA
polymerase 6 and polymerase e. Our results do not rule out either
polymerase as being the repair polymerase but provide strong
evidence that whichever polymerase fills-in the excision gap, it
carries out this particular reaction in a PCNA-dependent manner.
A previous study which reported increased PCNA
immunostaining in non S-phase human amnion cells following
UV irradiation also implicated PCNA in nucleotide excision
repair (27). Thus the in vivo results are in agreement with the
CFE system and the permeabilized cells.
To investigate whether PCNA directly participates in excision,
we conducted thymine dimer excision in the presence and
'absence' (less than 2.5 nM) of PCNA, and in the presence and
absence of dNTPs. We found that in the absence of PCNA and
dNTPs excision did occur, which led us to conclude that PCNA
is not a part of the 'excision nuclease' complex. A stimulatory
effect of PCNA on excision was observed in the absence of
dNTPs. The excision reaction was stimulated by dNTPs in the
absence or presence of PCNA with the most dramatic effect
achieved when both PCNA and dNTPs were added to the receptor
fraction which apparently contains all other repair proteins. The
most likely explanation for these findings is that the basal level
of 'nucleotide excision nuclease' is very low and that the enzyme
does not act catalytically in the absence of repair synthesis proteins
as is the case in E. coli (28-30). PCNA along with the repair
polymerase and other-yet unidentified proteins-release the
excision nuclease and enable it to turnover enzymatically. This
model (Fig. 5) might also explain the strong dependence of repair
synthesis on the human single-stranded DNA binding protein,
RF-A (31). In fact, in an E. coli cell-free repair synthesis system
containing both the excision nuclease and repair polymerase, no
repair synthesis at all was observed unless helicase H was included
in the reaction mixture (32) giving the impression that helicase
II might be involved in incision, whereas extensive studies have
shown that helicase II does not participate in repair prior to the
incision/excision reaction. Thus, it appears that the replication
complex which includes Pol 6 or Pol E, PCNA, RF-A, RF-C
and possibly other proteins (helicases) known to be required for
human DNA replication (33,34) carry our repair synthesis in
human nucleotide excision repair and in doing so enable the
excision nuclease to act catalytically.
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